Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2022 · View financials
Decision snapshot: GAP stock price vs CTXR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CTXR's multiple
Needs CTXR P/E.
Implied fair value · at GAP's multiple
Needs EPS (TTM) is negative, GAP P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GAP FY 2026 (ended Jan 31, 2026) · CTXR FY 2022 (ended Sep 30, 2022). Fiscal years are not aligned.
Trendline
Nine fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
GAP, INC · implied price per share
Bear
$27.22
Base
$32.02
Bull
$36.82
Citius Pharmaceuticals, Inc. · implied price per share
Bear
$0.09
Base
$0.11
Bull
$0.13
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.41x
0.01x
Net debt / EBITDA
Leverage against operating earnings
-0.81x
0.09x
Cash and equivalents
Liquid reserves on the balance sheet
$3.00B
$4.25M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ABERCROMBIE & FITCH CO /DE/
GAP vs ANF
AMERICAN EAGLE OUTFITTERS INC
GAP vs AEO
Childrens Place, Inc.
GAP vs PLCE
Victoria's Secret & Co.
GAP vs VSCO
Zomedica Corp.
GAP vs ZOM
Aquestive Therapeutics, Inc.
GAP vs AQST
ACADIA PHARMACEUTICALS INC
GAP vs ACAD
AMGEN INC
GAP vs AMGN
GILEAD SCIENCES, INC.
GAP vs GILD
AbbVie Inc.
GAP vs ABBV
$1.56B
$1.00M
Edwyn research
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote
